These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24138812)

  • 1. Hemophilia B Leyden and once mysterious cis-regulatory mutations.
    Funnell AP; Crossley M
    Trends Genet; 2014 Jan; 30(1):18-23. PubMed ID: 24138812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B.
    Crossley M; Brownlee GG
    Nature; 1990 May; 345(6274):444-6. PubMed ID: 2342576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilia B Leyden: the effect of mutations at position +13 on the liver-specific transcription of the factor IX gene.
    Reijnen MJ; Maasdam D; Bertina RM; Reitsma PH
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):341-8. PubMed ID: 8075306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
    Picketts DJ; Lillicrap DP; Mueller CR
    Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations.
    Picketts DJ; Mueller CR; Lillicrap D
    Blood; 1994 Nov; 84(9):2992-3000. PubMed ID: 7949171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.
    Funnell AP; Wilson MD; Ballester B; Mak KS; Burdach J; Magan N; Pearson RC; Lemaigre FP; Stowell KM; Odom DT; Flicek P; Crossley M
    Am J Hum Genet; 2013 Mar; 92(3):460-7. PubMed ID: 23472758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the
    Brenig B; Steingräber L; Shan S; Xu F; Hirschfeld M; Andag R; Spengeler M; Dietschi E; Mischke R; Leeb T
    Haematologica; 2019 Nov; 104(11):2307-2313. PubMed ID: 30846504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
    Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
    Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
    Furutani H
    Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
    Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B.
    Hall AJ; Chuansumrit A; Peake IR; Winship PR
    Thromb Haemost; 1994 Dec; 72(6):799-803. PubMed ID: 7740444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
    Kim HS; Kim JC; Lee YK; Kim JS; Park YS
    J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.
    Crossley M; Ludwig M; Stowell KM; De Vos P; Olek K; Brownlee GG
    Science; 1992 Jul; 257(5068):377-9. PubMed ID: 1631558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The current feature of the study on human coagulation factor IX mutant].
    Yan JB
    Yi Chuan; 2005 Sep; 27(5):833-8. PubMed ID: 16257919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative factor IX gene promoter in hemophilia B Leyden.
    Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
    Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutational Analysis of Hemophilia B in Russia: Molecular-Genetic Study].
    Surin VL; Demidova EY; Selivanova DS; Luchinina YA; Salomashkina VV; Pshenichnikova OS; Likhacheva EA
    Genetika; 2016 Apr; 52(4):466-73. PubMed ID: 27529981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.